Children’s Tumor Foundation Welcomes John Puziss as Chief Scientific and Impact Officer
The Children’s Tumor Foundation is pleased to announce the hiring of John Puziss, PhD as the new Chief Scientific and Impact Officer (CSIO).
About the role
John will oversee the CTF’s Science team and research portfolio, focusing on strategic investments and partnerships to expedite the development of therapies for individuals affected by Neurofibromatosis (NF).
Responsibilities
- Lead the Science team and research portfolio
- Guide strategic investments and partnerships to accelerate therapy development for NF patients
- Bring a proven track record of advancing promising science towards real-world impact
Requirements
With over two decades of leadership experience, particularly as Deputy Director of Technology Transfer at Dartmouth College, John brings extensive expertise in translating scientific discoveries into impactful solutions.
Qualifications
- Proven track record of advancing promising science toward real-world impact
- Leadership experience in technology transfer and research management
Skills
- Strategic thinking and vision
- Expertise in accelerating therapeutic development
- Ability to build and maintain strong partnerships
Benefits
This appointment underscores CTF’s dedication to bringing more approved therapies to NF patients more quickly. The CSIO role is specifically designed to drive the next phase of transformative therapies through targeted investments, barrier removal, and enhanced partnership-building.
Pay
Negotiable based on experience and qualifications.
Schedule
Full-time, based in New York City.
Contact
To learn more about John’s appointment, click here.